Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex
Annals of Neurosciences · 02.08.2026
DOI: 10.1177/09727531261448654 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurosciences, online erschienen am 02.08.2026. Verfasst von Jahnavi Dharwadkar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad, Telangana, India. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Depression is a pervasive mental health disorder that has been extensively studied, but effective treatment remains elusive. This is due to the lack of understanding regarding the underlying molecular mechanisms. Antidepressants usually target the monoaminergic system, but studies show that other neurotransmitters, such as acetylcholine (ACh), may be involved. Many clinical and preclinical studies show that increased ACh levels are associated with depression. Particularly, acetylcholinesterase (AChE) activity is shown to decrease in depression and antidepressants are known to increase it. However, it is not known whether this effect is direct or downstream.
Purpose
To check whether antidepressants can directly modulate AChE activity, we evaluated the effect of various classes of antidepressants on ex vivo AChE activity in the frontal cortex, hippocampus and striatum of male and female rats.
Methods
Briefly, sertraline (SER), escitalopram (ESC), amitriptyline (AT), duloxetine (DUL), bupropion (BUP) and ketamine (KET) were incubated with the brain tissue homogenates in a 96-well plate for 30 min, following which AChE activity was evaluated by modified Ellman’s method.
Results
SER and ESC increased AChE activity in the frontal cortex, while AT, DUL, BUP and KET did not affect it.
Conclusion
This points to a novel mechanism of action of selective serotonin reuptake inhibitors (SSRIs) and a potential target for developing new therapeutics with better efficacy and lower side effect profiles.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Hyderabad Campus, Hyderabad, Telangana, India.
- Department of Neurophysiology, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
ORCID-Profile: Jahnavi Dharwadkar, Amrutha R Nayak, B S Shankaranarayana Rao, Bettadapura N Srikumar
Zitieren
APA
Dharwadkar, J., Nayak, A. R., Rao, B. S. S., & Srikumar, B. N. (2026). Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex. Annals of Neurosciences. https://doi.org/10.1177/09727531261448654
Vancouver
Dharwadkar J, Nayak AR, Rao BSS, Srikumar BN. Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex. Annals of Neurosciences. 2026. doi:10.1177/09727531261448654
BibTeX
@article{Dharwadkar2026,
author = {Dharwadkar, Jahnavi and Nayak, Amrutha R and Rao, B S Shankaranarayana and Srikumar, Bettadapura N},
title = {Sertraline and Escitalopram But Not Other Antidepressants Increase Acetylcholinesterase Activity Ex Vivo in the Rat Frontal Cortex},
journal = {Annals of Neurosciences},
year = {2026},
doi = {10.1177/09727531261448654}
}
EUVIMED